BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 33500570)

  • 1. Cystic fibrosis-related diabetes onset can be predicted using biomarkers measured at birth.
    Lin YC; Keenan K; Gong J; Panjwani N; Avolio J; Lin F; Adam D; Barrett P; Bégin S; Berthiaume Y; Bilodeau L; Bjornson C; Brusky J; Burgess C; Chilvers M; Consunji-Araneta R; Côté-Maurais G; Dale A; Donnelly C; Fairservice L; Griffin K; Henderson N; Hillaby A; Hughes D; Iqbal S; Itterman J; Jackson M; Karlsen E; Kosteniuk L; Lazosky L; Leung W; Levesque V; Maille É; Mateos-Corral D; McMahon V; Merjaneh M; Morrison N; Parkins M; Pike J; Price A; Quon BS; Reisman J; Smith C; Smith MJ; Vadeboncoeur N; Veniott D; Viczko T; Wilcox P; van Wylick R; Cutting G; Tullis E; Ratjen F; Rommens JM; Sun L; Solomon M; Stephenson AL; Brochiero E; Blackman S; Corvol H; Strug LJ
    Genet Med; 2021 May; 23(5):927-933. PubMed ID: 33500570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pleiotropic modifiers of age-related diabetes and neonatal intestinal obstruction in cystic fibrosis.
    Aksit MA; Ling H; Pace RG; Raraigh KS; Onchiri F; Faino AV; Pagel K; Pugh E; Stilp AM; Sun Q; Blue EE; Wright FA; Zhou YH; Bamshad MJ; Gibson RL; Knowles MR; Cutting GR; Blackman SM;
    Am J Hum Genet; 2022 Oct; 109(10):1894-1908. PubMed ID: 36206743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for a causal relationship between early exocrine pancreatic disease and cystic fibrosis-related diabetes: a Mendelian randomization study.
    Soave D; Miller MR; Keenan K; Li W; Gong J; Ip W; Accurso F; Sun L; Rommens JM; Sontag M; Durie PR; Strug LJ
    Diabetes; 2014 Jun; 63(6):2114-9. PubMed ID: 24550193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic Modifiers of Cystic Fibrosis-Related Diabetes Have Extensive Overlap With Type 2 Diabetes and Related Traits.
    Aksit MA; Pace RG; Vecchio-Pagán B; Ling H; Rommens JM; Boelle PY; Guillot L; Raraigh KS; Pugh E; Zhang P; Strug LJ; Drumm ML; Knowles MR; Cutting GR; Corvol H; Blackman SM
    J Clin Endocrinol Metab; 2020 May; 105(5):1401-15. PubMed ID: 31697830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cystic Fibrosis-Related Diabetes Workshop: Research Priorities Spanning Disease Pathophysiology, Diagnosis, and Outcomes.
    Putman MS; Norris AW; Hull RL; Rickels MR; Sussel L; Blackman SM; Chan CL; Ode KL; Daley T; Stecenko AA; Moran A; Helmick MJ; Cray S; Alvarez JA; Stallings VA; Tuggle KL; Clancy JP; Eggerman TL; Engelhardt JF; Kelly A
    Diabetes; 2023 Jun; 72(6):677-689. PubMed ID: 37125945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Potential Causes of Cystic Fibrosis-Related Diabetes.
    Coderre L; Debieche L; Plourde J; Rabasa-Lhoret R; Lesage S
    Front Endocrinol (Lausanne); 2021; 12():702823. PubMed ID: 34394004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cystic fibrosis related diabetes in Europe: Prevalence, risk factors and outcome; Olesen et al.
    Olesen HV; Drevinek P; Gulmans VA; Hatziagorou E; Jung A; Mei-Zahav M; Stojnic N; Thomas M; Zolin A;
    J Cyst Fibros; 2020 Mar; 19(2):321-327. PubMed ID: 31680042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New Concepts in the Pathogenesis of Cystic Fibrosis-Related Diabetes.
    Moheet A; Moran A
    J Clin Endocrinol Metab; 2022 May; 107(6):1503-1509. PubMed ID: 35106591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenotype/genotype correlation and cystic fibrosis related diabetes mellitus (Italian Multicenter Study).
    Cotellessa M; Minicucci L; Diana MC; Prigione F; Di Febbraro L; Gagliardini R; Manca A; Battistini F; Taccetti G; Magazzù G; Padoan R; Pizzamiglio G; Raia V; Iapichino L; Cardella F; Grinzich G; Lucidi V; Tuccio G; Bignamini E; Salvatore D; Lorini R
    J Pediatr Endocrinol Metab; 2000; 13(8):1087-93. PubMed ID: 11085186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pancreas and islet morphology in cystic fibrosis: clues to the etiology of cystic fibrosis-related diabetes.
    Malik SS; Padmanabhan D; Hull-Meichle RL
    Front Endocrinol (Lausanne); 2023; 14():1269139. PubMed ID: 38075070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cystic Fibrosis-Related Diabetes Workshop: Research Priorities Spanning Disease Pathophysiology, Diagnosis, and Outcomes.
    Putman MS; Norris AW; Hull RL; Rickels MR; Sussel L; Blackman SM; Chan CL; Ode KL; Daley T; Stecenko AA; Moran A; Helmick MJ; Cray S; Alvarez JA; Stallings VA; Tuggle KL; Clancy JP; Eggerman TL; Engelhardt JF; Kelly A
    Diabetes Care; 2023 Jun; 46(6):1112-1123. PubMed ID: 37125948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of endocrine disease: Cystic fibrosis-related diabetes: novel pathogenic insights opening new therapeutic avenues.
    Barrio R
    Eur J Endocrinol; 2015 Apr; 172(4):R131-41. PubMed ID: 25336504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cystic fibrosis-related diabetes is caused by islet loss and inflammation.
    Hart NJ; Aramandla R; Poffenberger G; Fayolle C; Thames AH; Bautista A; Spigelman AF; Babon JAB; DeNicola ME; Dadi PK; Bush WS; Balamurugan AN; Brissova M; Dai C; Prasad N; Bottino R; Jacobson DA; Drumm ML; Kent SC; MacDonald PE; Powers AC
    JCI Insight; 2018 Apr; 3(8):. PubMed ID: 29669939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HMGB1 Is Increased by CFTR Loss of Function, Is Lowered by Insulin, and Increases In Vivo at Onset of CFRD.
    Montanini L; Cirillo F; Smerieri A; Pisi G; Giardino I; d'Apolito M; Spaggiari C; Bernasconi S; Amarri S; Street ME
    J Clin Endocrinol Metab; 2016 Mar; 101(3):1274-81. PubMed ID: 26760176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetes is associated with increased burden of gastrointestinal symptoms in adults with cystic fibrosis.
    Caley LR; Zagoya C; Duckstein F; White H; Shimmin D; Jones AM; Barrett J; Whitehouse JL; Floto RA; Mainz JG; Peckham DG
    J Cyst Fibros; 2023 Mar; 22(2):275-281. PubMed ID: 36710099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unraveling the complex genetic model for cystic fibrosis: pleiotropic effects of modifier genes on early cystic fibrosis-related morbidities.
    Li W; Soave D; Miller MR; Keenan K; Lin F; Gong J; Chiang T; Stephenson AL; Durie P; Rommens J; Sun L; Strug LJ
    Hum Genet; 2014 Feb; 133(2):151-61. PubMed ID: 24057835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Islet-intrinsic effects of CFTR mutation.
    Koivula FNM; McClenaghan NH; Harper AGS; Kelly C
    Diabetologia; 2016 Jul; 59(7):1350-1355. PubMed ID: 27033560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased expression of anion transporter SLC26A9 delays diabetes onset in cystic fibrosis.
    Lam AN; Aksit MA; Vecchio-Pagan B; Shelton CA; Osorio DL; Anzmann AF; Goff LA; Whitcomb DC; Blackman SM; Cutting GR
    J Clin Invest; 2020 Jan; 130(1):272-286. PubMed ID: 31581148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cystic fibrosis-related diabetes: an update on pathophysiology, diagnosis, and treatment.
    Alves C; Della-Manna T; Albuquerque CTM
    J Pediatr Endocrinol Metab; 2020 Jul; 33(7):835-843. PubMed ID: 32651985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CT imaging shows specific pancreatic abnormalities in persons with cystic fibrosis related diabetes.
    Alexandre-Heymann L; Puerto M; Martin C; Burnet E; Mosnier-Pudar H; Burgel PR; Larger E
    Sci Rep; 2023 Jun; 13(1):10433. PubMed ID: 37369827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.